Photo Credit: Freepick

The following is a summary of “Determinants of implementation of continuous glucose monitoring for patients with Insulin-Treated type 2 diabetes: a national survey of primary care providers,” published in the March 2025 issue of BMC Primary Care by Vimalananda et al. 

Researchers conducted a retrospective study to identify factors influencing continuous glucose monitoring (CGM) implementation from primary care providers (PCPs’) perspectives and its association with PCP’ intent to discuss CGM and facility-level uptake. 

They surveyed all PCPs in the VA health system (October 2023–April 2024) on CGM implementation for patients with type 2 diabetes on insulin. Multi-item scales measured perceived clinical benefits, workload capacity, CGM knowledge, resource access, and support, with responses on a 5-point Likert scale. Discussion likelihood and facility-level uptake were assessed using VA administrative data. Multivariable regression analyzed associations between CGM determinants, PCP intent, and uptake. 

The results showed that 79% of 1,373 respondents recognized CGM benefits, but only 8% had resource access and 5% had leadership support. PCP knowledge was most associated with intent to discuss CGM (B = 0.54, P < .001). Facility uptake was linked to CGM benefits (B = 0.10, P = .026) and leadership support (B = 0.18, P < .001). 

Investigators recognized CGM benefits but lacked the knowledge, resources, and workload capacity to manage it alone. PCP education and interprofessional support increased the likelihood of CGM use among eligible patients. 

Source: bmcprimcare.biomedcentral.com/articles/10.1186/s12875-025-02764-7